| Tag | Content |
|---|
EnhancerAtlas ID | HS034-13441 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr17:80289550-80291570 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MAFG | MA0659.1 | chr17:80290883-80290904 | TTACTGCGGAGTCAGCAAAAC | - | 6.39 | | MAFG | MA0659.1 | chr17:80290883-80290904 | TTACTGCGGAGTCAGCAAAAC | + | 6.53 | | MAFK | MA0496.2 | chr17:80290884-80290903 | TACTGCGGAGTCAGCAAAA | + | 6.56 | | MAFK | MA0496.2 | chr17:80290884-80290903 | TACTGCGGAGTCAGCAAAA | - | 6 | | Myog | MA0500.1 | chr17:80290481-80290492 | GACAGCTGCAG | + | 6.62 | | Tcf12 | MA0521.1 | chr17:80290481-80290492 | GACAGCTGCAG | + | 6.14 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_40455 | chr17:80289885-80291329 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGTTGAATGC CACGCAGTGG CTAAAAATCA GAGAGAGGGC AGGCGGCAGG GCGCGGCCCC 60
AGGGAAAGTG GCCAGGTGGG CGGTGACTGG CCGGGCAGCT CCGTGTGTGG CACAGGGAGA 120
CCTGGCACAG GGAGACCAGG TACAGGGAGA CGAGGCGCAC GGAGCCTCAA AACTTCTAGA 180
GTGGGCCGGG CGCGGTGGCG CATGCCTGCA ATCCCAGCAC TTTGGGAGGC TGAGGCAGGT 240
GGATCACCTG AGGTCGGGAG TTTGAGACCA GTCTGAACAA CGTGGTGAAA CCCCGTCTCT 300
ACTAAAAATA CAAAAAAATT AGCCGGGCGT GGTGGTGCAC GCCTGTAATC CCAGTTACTT 360
GGGAGGCTGA GGCAGGAGAA TCGCTTGAAC CAGGGAGGTG GAGGTTGTGG TGAGCCAAGA 420
TCTGGCCACT ACATTCCAGC CTGGGCAACA AGAGCGAAAC TCCGTCTCAA ACCAAACAAA 480
ACAAAAAACA AACTTCTAGA GCGGGAAAAG ATGGAGGCGG CAATCAGATT TCTCTCAAAC 540
CACGAACACA GGGGTCGGTA TCTGAGGCGC CGGCACCAGA CACGGCAGGG TCTGAGTGCT 600
CCCTGACAAG CGATGATGCG CAGGCTTGGA GCCATGCCAG TGACACGCCT AGGAAAGTTC 660
ACGCACCGCC CAGCACGCCT GCGCATGCCT GTTCCCGCTC CCTGGTGCCC CGGGCGCCTG 720
CCTGTCCCGG CTCCCATGGG TGCTGGGTGT GTGGAAGCTC CGGCCCCCTC GGGCTGGGTT 780
CATTGGGGTC CTCCTGTGTG GTCAGTGGAC TCTGTACCCC CACAGCACCT GAGGGGTGGC 840
TGACACTGCT TTCCCAGCTG CTGCAGGGGC TCAGGGAACA CAGGTGACCC CACGTCTCTA 900
CCGAGAATGA GCACACCAAC ACCTCTCAGA AGACAGCTGC AGCCTGCAGA GGCCATGGAC 960
CCCACCCAGG CCCACGGTGT GGACGGCTCT GCCCTGGTCT CTGCTGAGCC AGGCCCAGAG 1020
GGGACCCCAG GTGAGCAGCA AAGCCCCCCA GGCCTGGGGC TAGACCGGGC TAACCCTTCC 1080
TGCTCAGCAC CTGTTCACCT GTCCCCTCTG CTGGTGGCCT CCTGTCCTCC CGCTCTGGGC 1140
TCAGCAGCAG CCCCGTGGAG AGGCCCTGCC ACCACCCCCG CCCTGCTGGA GACAGGCCTC 1200
CTACGCGGGC TCCTGCAGCC GGTCGCCCTG GGCCTCCTAG AAGCCGGGGA TCCTCTGCTG 1260
ACCACCGGCA GAAAACGTGC TTCTCAAGCT GCAGGTGATT CACCAGTAGT GGGCAAGGAA 1320
CTGAATGTGG TGATTACTGC GGAGTCAGCA AAACCCGCGT GAGAACGGGC AGCTGAGGGC 1380
CTGCCGGGTG AGGGAAGCCT CACGGTTCCT GTTTCATGAG TTTGCTGTGA GTGCACACGA 1440
GGCTGTGGCT GTGGAGTGTG CAACAGTCCA CGCGTGCCTG CGTGTGCTCA TGTGCGTGTG 1500
TCCACCAGCT TGTGTGCACG CATATGAGCG AGTGCGTTTT GCTCCCAGCT TGGTCGCAGC 1560
GACGGCGCAG GGAACCCCGG GTGAGGCCGA GGACCGGGAA GGGAGGAGGG GGCTCCGACC 1620
CATCGGACTT AGGGGAGCCC CGGGTCCGAG ACGCCGCCTC TGTCCCTTCA AGAGTCGAGC 1680
CTGGCGCACA GGGCAGGGAC GCGGGTCCCC ACACCGGCCG GCAGCTCGTT CCCGCCCATA 1740
CTCGGGTACG CCCGCTGCGA CCCCGCCCGC CTGGCCTGCG ACGCACGCTC AGGGCCAGCG 1800
GGGGGTGACG GTCCCAGAGG CAGAGGCGCC GCAGCCCCAG AGTCCCCATC CCTGCGCGGA 1860
CCGGCAACCC CAGTGCACCA AGAGGCCCTA ACACCGAGCC CCCAGCACCG AGTCCCCAGC 1920
ACCGGGCCCT CAGCACCGAG TCCCCAGCAC CGAGTCCCCA GCACCGAGTC CCCAGCACCG 1980
AGCCCGCCCC TCTGGTTCCC CCGCCCGCCC CTCTCCGCGC 2020
|
